China’s Listed Pet Cos’ 2026: Revenue Rises 15.15%, Profit Falls 46.75%

China’s seven major listed pet companies delivered strong top-line growth in the first half of 2026, but profitability deteriorated sharply. Combined revenue reached approximately ¥11.386 billion, up 15.15% year on year, while aggregate attributable net profit fell 46.75% to about ¥482 million. The divergence points to a pet industry that is still expanding, but where raw-material costs, exchange rates, overseas margins and investment in brands are putting pressure on earnings.

Revenue Growth Is Broad, Profitability Is Not

The seven A-share companies — G-Bits? No. The relevant pet-sector group comprises 乖宝宠物, 中宠股份, 佩蒂股份, 天元宠物, 依依股份, 源飞宠物 and 路斯股份 — had all reported their 2026 first-half results by September 3.

Together, the companies generated:

The figures reveal an unusually broad “revenue up, profit down” pattern. Six of the seven companies increased revenue, but none increased attributable net profit.

That makes the first-half results more significant than the aggregate numbers alone suggest: China’s listed pet industry is demonstrating demand resilience while simultaneously entering a period of margin restructuring.

The Two Largest Players Show the Contradiction Clearly

乖宝宠物: Main Food Drives Growth, Profit Falls – 乖宝宠物 remained the largest company in the group by first-half revenue. It reported:

• Revenue: ¥3.543 billion

• Revenue growth: +10.01%

• Attributable net profit: ¥191 million

• Net-profit decline: −49.57%

• Main-food revenue: ¥2.332 billion

• Main-food growth: +23.87%

• Main-food share of revenue: 65.82%

The strategic significance is substantial.

Main-food revenue grew more than twice as fast as total company revenue, suggesting that the company’s product mix is moving toward its own branded, higher-value food business rather than relying purely on lower-value manufacturing or distribution. But the earnings result shows that mix improvement does not automatically translate into immediate profit expansion.

Zhongchong Leads Revenue Growth — But Overseas Margins Collapse

中宠股份 produced the fastest revenue growth among the seven companies. H1 2026:

• Revenue: ¥3.281 billion

• Growth: +34.88%

• Attributable net profit: ¥127 million

• Decline: −37.63%

Its overseas business generated ¥2.138 billion, up 35.78%, demonstrating that international demand remained strong. But the margin picture was much weaker.

Reported overseas gross margin fell from 27.95% to 19.37%, according to industry analysis cited by Economic Information Daily. Domestic gross margin was approximately 38.1%, illustrating the substantial profitability gap between domestic and overseas operations. This is one of the clearest indicators that the current problem is not simply demand.

Orders can grow rapidly while the economics of those orders deteriorate.

Export-Oriented Companies Face a Different Margin Challenge

The earnings pressure was especially visible among companies with significant export exposure.

*Source: company H1 2026 disclosures as compiled by Economic Information Daily/China Fund. *

The table shows that the earnings deterioration is widespread rather than concentrated in a single company. 佩蒂股份 recorded the largest profit decline at 69.25%, despite broadly stable revenue.

At the other end of the spectrum, 路斯股份 increased revenue 26.17% while limiting its net-profit decline to 18.56%, making it one of the relatively more resilient performers in the group.

Why Are Profits Falling?

Three factors stand out from the companies’ reported results and industry analysis.

1. Currency Is Working Against Exporters – The appreciation of the Chinese yuan has become an important earnings headwind for export-oriented pet companies.

Companies receiving substantial foreign-currency revenue can experience lower translated revenue and weaker profitability when exchange rates move unfavourably. The issue is particularly visible at 中宠股份, where increased overseas sales coincided with substantially lower overseas gross margin.

2. Cost Growth Is Outrunning Revenue – For 中宠股份, first-half operating costs increased approximately 45.69%, significantly faster than its 34.88% revenue growth. That gap provides a useful illustration of the industry’s current economics:

Revenue +34.9% → Operating cost +45.7% → Profit −37.6%

Strong sales growth therefore does not guarantee operating leverage.

3. Brand Building Requires Upfront Investment – The industry’s strategic direction is changing. Chinese pet companies are increasingly moving from:

OEM/ODM → own brands → premium food → functional nutrition → prescription/therapeutic products

This transition can initially depress profitability because companies must invest in advertising, channels, product development, distribution and consumer acquisition before achieving the scale required to absorb those costs. The first-half results therefore partly represent a transition cost associated with moving up the value chain.

Premiumization Is Becoming the Industry’s Central Strategy

Despite the sharp fall in profits, the underlying industry thesis has not weakened. China’s urban dog-and-cat consumption market reached approximately ¥312.6 billion in 2025, up 4.1%, according to the 2026 China Pet Industry White Paper cited by Economic Information Daily.

The same source projects the market to reach approximately ¥405 billion by 2028. That creates a potentially attractive environment for companies capable of capturing a larger share of consumer spending rather than simply increasing shipment volumes. The industry’s premiumization strategy is increasingly focused on:

• premium dry and wet food;

• functional pet food;

• high-protein formulations;

• scientifically formulated nutrition;

• prescription diets;

• supplements;

• dental and digestive health;

• weight management;

• life-stage nutrition; and

• specialized products for ageing pets.

The strategic shift is from “feeding the pet” to “managing the pet’s health.”

Main Food Is Emerging as the Strategic Battleground

The performance of 乖宝宠物 is particularly revealing. Its main-food business grew 23.87%, compared with 10.01% overall revenue growth, and represented nearly two-thirds of revenue. This suggests that leading companies increasingly view pet food — particularly branded food — as the core platform through which they can control consumer relationships, pricing, product innovation and repeat purchases.

That is strategically different from an export-oriented OEM model, where the manufacturer may have limited control over the consumer-facing brand and therefore less pricing power.

Domestic Brand Development Versus Export Manufacturing

China’s listed pet industry is effectively developing along two parallel tracks.

Export model – Manufacturing → international customer → large volume → lower brand control → FX/trade exposure

Domestic premium model – Own brand → consumer relationship → differentiated product → higher potential pricing power → greater marketing investment

The first model can generate scale rapidly, but margins can be vulnerable to currency movements, tariffs, customer bargaining power and input costs. The second model potentially offers greater long-term margin control but requires sustained investment.

The current earnings data suggest that many listed companies are paying the cost of this transition before fully capturing its benefits.

Industry Concentration Remains Relatively Low

The Chinese pet-food market remains fragmented. Industry research estimates that in 2024 the top five pet-food companies accounted for approximately 25.4% of industry company share, while the top 10 accounted for 32.7%. Brand concentration was even lower, with the top five brands accounting for approximately 18.9% and the top 10 approximately 26.0%.

This fragmentation creates both opportunity and risk. There is substantial room for leading companies to capture share, but competition for that share can also require heavy spending on marketing, e-commerce platforms, retail channels and product development.

The Premiumization Paradox

The first-half results expose an important paradox. Premiumization can improve the quality of revenue without immediately improving the quality of earnings. A company may sell more premium food but simultaneously spend more on:

• brand awareness;

• digital marketing;

• celebrity/influencer campaigns;

• retail distribution;

• product development;

• veterinary/scientific positioning;

• overseas expansion; and

• manufacturing upgrades.

Consequently, investors should distinguish between revenue premiumization and margin premiumization. The first is already visible. The second still has to be demonstrated.

What Investors Should Watch in H2 2026

The second half of 2026 will provide several important tests for the sector.

1. Gross-margin recovery – The key question is whether higher-value products eventually translate into improved gross margins.

2. Domestic versus overseas mix – Companies with faster-growing domestic branded businesses may gradually become less exposed to currency and international trade volatility.

3. Marketing efficiency – Premium brands require consumer acquisition. The critical metric will be whether additional marketing spending produces proportionately greater recurring sales.

4. Raw-material costs – Pet food margins remain sensitive to meat, poultry, fish, grains and other formulation inputs.

5. Functional and prescription nutrition – These categories could provide higher-value growth if companies establish credible scientific differentiation and veterinary channels.

6. Export economics – The strong revenue growth reported by several exporters needs to be evaluated alongside exchange rates, tariffs, customer concentration and actual gross-margin performance.

Analyst View: The Sector Is Growing — But the Business Model Is Being Repriced

The 2026 first-half results do not indicate a collapse in China’s pet market. They show something more nuanced.

Demand is growing. Revenue is growing. But the cost of capturing that growth is rising faster than many companies can currently monetize it. The ¥11.386 billion combined revenue generated by the seven listed companies demonstrates continued sector expansion. But the corresponding ¥482 million net profit — down 46.75% — shows that growth is currently being purchased at a high earnings cost.

The strategic winners are unlikely to be determined simply by who grows revenue fastest. They will be determined by which companies can convert:

Premiumization → brand strength → pricing power → repeat purchase → operating leverage → sustainable margins.

For China’s pet industry, that is the next phase of the growth story. The first phase was scale. The next phase is value capture.